226 related articles for article (PubMed ID: 20974861)
1. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.
Xu D; Fuster MM; Lawrence R; Esko JD
J Biol Chem; 2011 Jan; 286(1):737-45. PubMed ID: 20974861
[TBL] [Abstract][Full Text] [Related]
2. Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.
Muthusamy A; Cooper CR; Gomes RR
BMC Biochem; 2010 Nov; 11():43. PubMed ID: 21047416
[TBL] [Abstract][Full Text] [Related]
3. Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate.
Nishiguchi KM; Kataoka K; Kachi S; Komeima K; Terasaki H
PLoS One; 2010 Oct; 5(10):e13493. PubMed ID: 20975989
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
[TBL] [Abstract][Full Text] [Related]
5. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
6. Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice.
Njau F; Shushakova N; Schenk H; Wulfmeyer VC; Bollin R; Menne J; Haller H
PLoS One; 2020; 15(1):e0218494. PubMed ID: 31935212
[TBL] [Abstract][Full Text] [Related]
7. TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation.
Yang GL; Zhao Z; Qin TT; Wang D; Chen L; Xiang R; Xi Z; Jiang R; Zhang ZS; Zhang J; Li LY
FASEB J; 2017 May; 31(5):2001-2012. PubMed ID: 28183800
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C).
Yin X; Johns SC; Lawrence R; Xu D; Reddi K; Bishop JR; Varner JA; Fuster MM
J Biol Chem; 2011 Apr; 286(17):14952-62. PubMed ID: 21343305
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
Teran M; Nugent MA
J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
[TBL] [Abstract][Full Text] [Related]
10. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
[TBL] [Abstract][Full Text] [Related]
11. The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.
Beckouche N; Bignon M; Lelarge V; Mathivet T; Pichol-Thievend C; Berndt S; Hardouin J; Garand M; Ardidie-Robouant C; Barret A; Melino G; Lortat-Jacob H; Muller L; Monnot C; Germain S
Sci Signal; 2015 Jul; 8(385):ra70. PubMed ID: 26175493
[TBL] [Abstract][Full Text] [Related]
12. Engineering a vascular endothelial growth factor 165-binding heparan sulfate for vascular therapy.
Wang C; Poon S; Murali S; Koo CY; Bell TJ; Hinkley SF; Yeong H; Bhakoo K; Nurcombe V; Cool SM
Biomaterials; 2014 Aug; 35(25):6776-86. PubMed ID: 24854095
[TBL] [Abstract][Full Text] [Related]
13. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
[TBL] [Abstract][Full Text] [Related]
14. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
15. Vascular Endothelial Growth Factor 165-Binding Heparan Sulfate Promotes Functional Recovery From Cerebral Ischemia.
Chan SJ; Esposito E; Hayakawa K; Mandaville E; Smith RAA; Guo S; Niu W; Wong PT; Cool SM; Lo EH; Nurcombe V
Stroke; 2020 Sep; 51(9):2844-2853. PubMed ID: 32772683
[TBL] [Abstract][Full Text] [Related]
16. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
17. Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins.
Ashikari-Hada S; Habuchi H; Kariya Y; Kimata K
J Biol Chem; 2005 Sep; 280(36):31508-15. PubMed ID: 16027124
[TBL] [Abstract][Full Text] [Related]
18. The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro.
Dallinga MG; Habani YI; Schimmel AWM; Dallinga-Thie GM; van Noorden CJF; Klaassen I; Schlingemann RO
Cells; 2021 Apr; 10(4):. PubMed ID: 33923753
[TBL] [Abstract][Full Text] [Related]
19. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis.
Fuster MM; Wang L; Castagnola J; Sikora L; Reddi K; Lee PH; Radek KA; Schuksz M; Bishop JR; Gallo RL; Sriramarao P; Esko JD
J Cell Biol; 2007 May; 177(3):539-49. PubMed ID: 17470635
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA).
Kasza Z; Fredlund Fuchs P; Tamm C; Eriksson AS; O'Callaghan P; Heindryckx F; Spillmann D; Larsson E; Le Jan S; Eriksson I; Gerwins P; Kjellén L; Kreuger J
J Biol Chem; 2013 Sep; 288(36):25956-25963. PubMed ID: 23884416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
